πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6509319

EDTA and other chelators with or without antifungal antimicrobial agents for the preventio

The Board of Regents of the University of Texas System Β· Granted Tue Jan 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6509317

Method of treating chronic cardiac disease

The Board of Regents of the University of Texas System Β· Granted Tue Jan 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6503498

Apolipoprotein A-1 adenovirus vector compositions and methods

The Board of Regents of the University of Texas System Β· Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6503914

Thienopyrimidine-based inhibitors of the Src family

The Board of Regents of the University of Texas System Β· Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6503915

Composition and method for treatment of cerebral ischemia

The Board of Regents of the University of Texas System Β· Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6503916

Treatment of ischemic brain injury

The Board of Regents of the University of Texas System Β· Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6500834

Composition and method for treatment of cerebral ischemia

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6500798

Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress

The Board of Regents of the University of Texas System Β· Granted Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6492104

EIA test using nondenatured HIV antigen for early detection of HIV infection

The Board of Regents of the University of Texas System Β· Granted Tue Dec 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6489163

Ribozyme mediated inactivation of the androgen receptor

The Board of Regents of the University of Texas System Β· Granted Tue Dec 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6482411

Methods of reducing bone loss with CD40 ligand

The Board of Regents of the University of Texas System Β· Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6482803

Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A

The Board of Regents of the University of Texas System Β· Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6482795

Tumor suppressor designated TS10q23.3

The Board of Regents of the University of Texas System Β· Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6479662

Antitumor dibenzofluorene derivatives

The Board of Regents of the University of Texas System Β· Granted Tue Nov 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6465001

Treating medical conditions by polymerizing macromers to form polymeric materials

The Board of Regents of the University of Texas System Β· Granted Tue Oct 15 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6461613

Methods and compositions for the selective regulation of chorionic prostanoids

The Board of Regents of the University of Texas System Β· Granted Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6461640

Local delivery of fibrinolysis enhancing agents

The Board of Regents of the University of Texas System Β· Granted Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6455541

Suppression, by 5-lipoxygenase inhibitors, of bone resorption

The Board of Regents of the University of Texas System Β· Granted Tue Sep 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6451312

VEGF-gelonin for targeting the vasculature of solid tumors

The Board of Regents of the University of Texas System Β· Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6448472

Genetic and epigenetic manipulation of ABC transporters and ectophosphatases for the confe

The Board of Regents of the University of Texas System Β· Granted Tue Sep 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6448072

Transcription factors related to TFIIA

The Board of Regents of the University of Texas System Β· Granted Tue Sep 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6444872

Large animal model of invasive pulmonary aspergillosis in an immunocompromised host

The Board of Regents of the University of Texas System Β· Granted Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6444446

Calcium binding proteolipid compositions and methods

The Board of Regents of the University of Texas System Β· Granted Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6437116

VMP-like sequences of pathogenic borrelia

The Board of Regents of the University of Texas System Β· Granted Tue Aug 20 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired